NCT06471374 Pathophysiology of Circadian Rhythm Delayed Sleep Wake Phase Disorder
| NCT ID | NCT06471374 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Colorado, Boulder |
| Condition | Delayed Sleep Phase Syndrome |
| Study Type | INTERVENTIONAL |
| Enrollment | 66 participants |
| Start Date | 2024-04-02 |
| Primary Completion | 2028-07 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 66 participants in total. It began in 2024-04-02 with a primary completion date of 2028-07.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this study is to understand factors that contribute to delayed sleep wake phase disorder (DSWPD). The investigators will examine whether patients with DSWPD exhibit alterations in circadian rhythms and sensitivity to light compared to healthy controls. The investigators will also test a new method of predicting circadian rhythms form a blood sample.
Eligibility Criteria
Inclusion Criteria: * Delayed sleep wake phase disorder diagnosis * Altitude history: currently residing at Denver altitude or higher * BMI normal to moderately overweight Exclusion Criteria: * Recent medical condition * Psychiatric disorder * Sleep disorder * Medication use
Contact & Investigator
Kenneth Wright, PhD
PRINCIPAL INVESTIGATOR
University of Colorado, Boulder
Frequently Asked Questions
Who can join the NCT06471374 clinical trial?
This trial is open to participants of all sexes, aged 16 Years or older, up to 40 Years, studying Delayed Sleep Phase Syndrome. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06471374 currently recruiting?
Yes, NCT06471374 is actively recruiting participants. Contact the research team at sleep.study@colorado.edu for enrollment information.
Where is the NCT06471374 trial being conducted?
This trial is being conducted at Boulder, United States, Chicago, United States.
Who is sponsoring the NCT06471374 clinical trial?
NCT06471374 is sponsored by University of Colorado, Boulder. The principal investigator is Kenneth Wright, PhD at University of Colorado, Boulder. The trial plans to enroll 66 participants.